IV vs oral anti-nausea drugs to prevent chemo nausea
Treatments studied
Part of Cancer, Skin clinical trials.
This Phase 4 study tests whether taking anti-nausea medicines through a vein (IV) or by mouth (oral) works better when combined to prevent nausea from breast cancer chemotherapy. It also checks safety, meaning side effects and how well people tolerate the medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 to 70.
- You have confirmed invasive breast cancer and you are starting adjuvant (after surgery) or neoadjuvant (before surgery) chemotherapy, with no prior chemo for this current breast cancer.
- You have no other cancer and no known far-away (distant) spread of your breast cancer.
- Your performance status is good (ECOG 0–1), meaning you can do most daily activities.
- Your blood tests and organ function are within required limits (including white blood cells, neutrophils, platelets, and liver/kidney/bilirubin values).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.
This study looks at whether adding aromatherapy to standard anti-nausea medication helps prevent nausea and vomiting caused by strong chemotherapy in breast cancer patients. If it works, aromatherapy could be an easy, drug-free way to feel better during treatment.
This trial tests a non-invasive device that stimulates a nerve in your ear to help prevent nausea caused by chemotherapy. It is for people with breast cancer who are about to start a specific type of chemo (anthracycline and cyclophosphamide).
This trial tests whether adding acupuncture to standard care can help manage nausea, vomiting, and other stomach symptoms caused by chemotherapy in people with early-stage breast cancer. It is for those about to start their first round of strong chemo.
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.